STAT News

MARCH 9, 2023

WASHINGTON — President Biden made lowering drug prices a key part of his budget with proposals to expand Medicare drug price negotiation, squeeze more rebates out of drug companies, and lower the cost of insulin for everyone with insurance. The request made Thursday also details a $7.2

Cosmetics 98

Cosmetics Drugs Insulin Regulation 98

pharmaphorum

JULY 27, 2021

Illinois-headquartered Apar – which makes inhalers, syringe components, eye drop bottles and other delivery systems for pharmaceuticals, cosmetics and other sectors – is paying €8.70 per share in the initial deal, which will give it a 64.6% stake in the company. The deal values Voluntis at around $79 million (around $95 million).

Drug Delivery 109

Drug Delivery Insulin Cosmetics Development 109

XTalks

FEBRUARY 8, 2021

While there are currently six biosimilars for AbbVie’s Humira (adalimumab) that have been approved by the regulator, the company’s patents prevent biosimilars from being launched until 2023. The regulator allows biosimilars to show slight differences in clinically inactive components of a product.

Production 78

Production Insulin Branding Generic Drugs 78

XTalks

SEPTEMBER 28, 2023

This is because the US has more lenient food ingredient regulations, potentially exposing consumers to carcinogens and harmful chemicals. Using rBST results in higher concentrations of insulin-like growth factor 1 (IGF-1), a protein typically present in milk.

Hormones 52

Hormones Containment Production Cosmetics 52

XTalks

JANUARY 25, 2023

The Federal Food, Drug, and Cosmetic Act (FFDCA) gives the FDA the legal authority to approve drugs for both humans and animals. A drug intended for use in animals is called a new animal drug and the FDA’s Center for Veterinary Medicine (CVM) approves and regulates new animal drugs.

FDA Approval 52

FDA Approval Drugs Life Science Cosmetics 52

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. It is a dipeptidyl peptidase-4 inhibitor that keeps insulin levels stable and reduces the amount of glucose produced by the body. Merck’s total global revenue from Lagevrio was $5.68

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharmacy Checkers

MARCH 20, 2020

It could be done through special waivers or general regulation. It should be a general regulation so that there’s no gray about the policy and Americans don’t have to go through unnecessary red tape to go buy a more affordable prescription drug. For people who take insulin, especially to treat type 1 diabetes, this could be lifesaving.

Drugs 59

Drugs Pharmacy Cosmetics Regulation 59